{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","record_version":"public-1:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-24T04:45:10.88591+00:00","published_at":"2026-10-24T04:45:10.88591+00:00","section":"relationships","data":{"state":"PUBLISHED","relationships":[{"relationship_id":"alpha:relationship:seat_on:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:9:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"seat_on","from_id":"alpha:person:amir-elstein","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Amir Elstein","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":"2009-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:10:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"seat_on","from_id":"alpha:person:chen-lichtenstein","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Chen Lichtenstein","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":"2024-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:11:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"seat_on","from_id":"alpha:person:gerald-lieberman","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Gerald Lieberman","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":"2015-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:12:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"seat_on","from_id":"alpha:person:perry-d-nisen","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Perry D. Nisen","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":"2017-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:12","evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:13:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"seat_on","from_id":"alpha:person:prof-ronit-satchi-fainaro-tevjf","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Prof. Ronit Satchi-Fainaro","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":"2018-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:13","evidence_ids":["alpha:projection-evidence:document:17461fa3d5493d3b30182a87e5400dc5c54917c430dd17c64ebd57ff63626069"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:14:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"seat_on","from_id":"alpha:person:richard-francis","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Richard Francis","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":"2023-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:14","evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:15:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"seat_on","from_id":"alpha:person:roberto-mignone","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Roberto Mignone","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":"2017-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:15","evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:16:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"seat_on","from_id":"alpha:person:rosemary-a-crane","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Rosemary A. Crane","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":"2015-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:16","evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:8:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"seat_on","from_id":"alpha:person:dr-sol-j-barer","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Sol J. Barer","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":"2015-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:17461fa3d5493d3b30182a87e5400dc5c54917c430dd17c64ebd57ff63626069"]},{"relationship_id":"alpha:relationship:chairs_board:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:8:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"chairs_board","from_id":"alpha:person:dr-sol-j-barer","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Sol J. Barer","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":"2015-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:17461fa3d5493d3b30182a87e5400dc5c54917c430dd17c64ebd57ff63626069"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:17:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"seat_on","from_id":"alpha:person:tal-zaks","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Tal Zaks","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":"2021-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:17","evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:27:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"committee_of","from_id":"alpha:committee:teva-pharmaceutical-industries-ltd:audit","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Audit","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:27","evidence_ids":["alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60"]},{"relationship_id":"alpha:relationship:chairs:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:27:committee:teva-pharmaceutical-industries-ltd:audit","relationship_type":"chairs","from_id":"alpha:person:gerald-lieberman","to_id":"alpha:committee:teva-pharmaceutical-industries-ltd:audit","from_label":"Gerald Lieberman","to_label":"Audit","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:27","evidence_ids":["alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60"]},{"relationship_id":"alpha:relationship:member_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:27:committee:teva-pharmaceutical-industries-ltd:audit","relationship_type":"member_of","from_id":"alpha:person:amir-elstein","to_id":"alpha:committee:teva-pharmaceutical-industries-ltd:audit","from_label":"Amir Elstein","to_label":"Audit","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:27","evidence_ids":["alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:11:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"committee_of","from_id":"alpha:committee:teva-pharmaceutical-industries-ltd:audit-chair-human-resources-and-compensation-finance-and-investment","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Audit · Chair; Human Resources and Compensation; Finance and Investment","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":"2015-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"]},{"relationship_id":"alpha:relationship:member_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:11:committee:teva-pharmaceutical-industries-ltd:audit-chair-human-resources-and-compensation-finance-and-investment","relationship_type":"member_of","from_id":"alpha:person:gerald-lieberman","to_id":"alpha:committee:teva-pharmaceutical-industries-ltd:audit-chair-human-resources-and-compensation-finance-and-investment","from_label":"Gerald Lieberman","to_label":"Audit · Chair; Human Resources and Compensation; Finance and Investment","valid_from":"2015-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:10:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"committee_of","from_id":"alpha:committee:teva-pharmaceutical-industries-ltd:audit-compliance-finance-and-investment","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Audit; Compliance; Finance and Investment","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":"2024-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"]},{"relationship_id":"alpha:relationship:member_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:10:committee:teva-pharmaceutical-industries-ltd:audit-compliance-finance-and-investment","relationship_type":"member_of","from_id":"alpha:person:chen-lichtenstein","to_id":"alpha:committee:teva-pharmaceutical-industries-ltd:audit-compliance-finance-and-investment","from_label":"Chen Lichtenstein","to_label":"Audit; Compliance; Finance and Investment","valid_from":"2024-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:32:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"committee_of","from_id":"alpha:committee:teva-pharmaceutical-industries-ltd:compliance","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Compliance","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:32","evidence_ids":["alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60"]},{"relationship_id":"alpha:relationship:member_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:32:committee:teva-pharmaceutical-industries-ltd:compliance","relationship_type":"member_of","from_id":"alpha:person:chen-lichtenstein","to_id":"alpha:committee:teva-pharmaceutical-industries-ltd:compliance","from_label":"Chen Lichtenstein","to_label":"Compliance","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:32","evidence_ids":["alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:13:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"committee_of","from_id":"alpha:committee:teva-pharmaceutical-industries-ltd:compliance-science-and-technology-corporate-governance-and-nominating","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Compliance; Science and Technology; Corporate Governance and Nominating","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":"2018-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:13","evidence_ids":["alpha:projection-evidence:document:17461fa3d5493d3b30182a87e5400dc5c54917c430dd17c64ebd57ff63626069"]},{"relationship_id":"alpha:relationship:member_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:13:committee:teva-pharmaceutical-industries-ltd:compliance-science-and-technology-corporate-governance-and-nominating","relationship_type":"member_of","from_id":"alpha:person:prof-ronit-satchi-fainaro-tevjf","to_id":"alpha:committee:teva-pharmaceutical-industries-ltd:compliance-science-and-technology-corporate-governance-and-nominating","from_label":"Prof. Ronit Satchi-Fainaro","to_label":"Compliance; Science and Technology; Corporate Governance and Nominating","valid_from":"2018-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:13","evidence_ids":["alpha:projection-evidence:document:17461fa3d5493d3b30182a87e5400dc5c54917c430dd17c64ebd57ff63626069"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:36:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"committee_of","from_id":"alpha:committee:teva-pharmaceutical-industries-ltd:corporate-governance-and-nominating","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Corporate Governance and Nominating","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:36","evidence_ids":["alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60"]},{"relationship_id":"alpha:relationship:chairs:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:36:committee:teva-pharmaceutical-industries-ltd:corporate-governance-and-nominating","relationship_type":"chairs","from_id":"alpha:person:roberto-mignone","to_id":"alpha:committee:teva-pharmaceutical-industries-ltd:corporate-governance-and-nominating","from_label":"Roberto Mignone","to_label":"Corporate Governance and Nominating","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:36","evidence_ids":["alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60"]},{"relationship_id":"alpha:relationship:member_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:36:committee:teva-pharmaceutical-industries-ltd:corporate-governance-and-nominating","relationship_type":"member_of","from_id":"alpha:person:amir-elstein","to_id":"alpha:committee:teva-pharmaceutical-industries-ltd:corporate-governance-and-nominating","from_label":"Amir Elstein","to_label":"Corporate Governance and Nominating","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:36","evidence_ids":["alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:15:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"committee_of","from_id":"alpha:committee:teva-pharmaceutical-industries-ltd:corporate-governance-and-nominating-chair-finance-and-investment-audit","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Corporate Governance and Nominating · Chair; Finance and Investment; Audit","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":"2017-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:15","evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"]},{"relationship_id":"alpha:relationship:member_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:15:committee:teva-pharmaceutical-industries-ltd:corporate-governance-and-nominating-chair-finance-and-investment-audit","relationship_type":"member_of","from_id":"alpha:person:roberto-mignone","to_id":"alpha:committee:teva-pharmaceutical-industries-ltd:corporate-governance-and-nominating-chair-finance-and-investment-audit","from_label":"Roberto Mignone","to_label":"Corporate Governance and Nominating · Chair; Finance and Investment; Audit","valid_from":"2017-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:15","evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:9:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"committee_of","from_id":"alpha:committee:teva-pharmaceutical-industries-ltd:corporate-governance-and-nominating-audit-finance-and-investment","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Corporate Governance and Nominating; Audit; Finance and Investment","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":"2009-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"]},{"relationship_id":"alpha:relationship:member_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:9:committee:teva-pharmaceutical-industries-ltd:corporate-governance-and-nominating-audit-finance-and-investment","relationship_type":"member_of","from_id":"alpha:person:amir-elstein","to_id":"alpha:committee:teva-pharmaceutical-industries-ltd:corporate-governance-and-nominating-audit-finance-and-investment","from_label":"Amir Elstein","to_label":"Corporate Governance and Nominating; Audit; Finance and Investment","valid_from":"2009-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:40:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"committee_of","from_id":"alpha:committee:teva-pharmaceutical-industries-ltd:finance-and-investment","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Finance and Investment","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:40","evidence_ids":["alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60"]},{"relationship_id":"alpha:relationship:member_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:40:committee:teva-pharmaceutical-industries-ltd:finance-and-investment","relationship_type":"member_of","from_id":"alpha:person:amir-elstein","to_id":"alpha:committee:teva-pharmaceutical-industries-ltd:finance-and-investment","from_label":"Amir Elstein","to_label":"Finance and Investment","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:40","evidence_ids":["alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:45:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"committee_of","from_id":"alpha:committee:teva-pharmaceutical-industries-ltd:human-resources-and-compensation","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Human Resources and Compensation","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:45","evidence_ids":["alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60"]},{"relationship_id":"alpha:relationship:chairs:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:45:committee:teva-pharmaceutical-industries-ltd:human-resources-and-compensation","relationship_type":"chairs","from_id":"alpha:person:rosemary-a-crane","to_id":"alpha:committee:teva-pharmaceutical-industries-ltd:human-resources-and-compensation","from_label":"Rosemary A. Crane","to_label":"Human Resources and Compensation","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:45","evidence_ids":["alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60"]},{"relationship_id":"alpha:relationship:member_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:45:committee:teva-pharmaceutical-industries-ltd:human-resources-and-compensation","relationship_type":"member_of","from_id":"alpha:person:gerald-lieberman","to_id":"alpha:committee:teva-pharmaceutical-industries-ltd:human-resources-and-compensation","from_label":"Gerald Lieberman","to_label":"Human Resources and Compensation","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:45","evidence_ids":["alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:16:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"committee_of","from_id":"alpha:committee:teva-pharmaceutical-industries-ltd:human-resources-and-compensation-chair-science-and-technology","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Human Resources and Compensation · Chair; Science and Technology","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":"2015-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:16","evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"]},{"relationship_id":"alpha:relationship:member_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:16:committee:teva-pharmaceutical-industries-ltd:human-resources-and-compensation-chair-science-and-technology","relationship_type":"member_of","from_id":"alpha:person:rosemary-a-crane","to_id":"alpha:committee:teva-pharmaceutical-industries-ltd:human-resources-and-compensation-chair-science-and-technology","from_label":"Rosemary A. Crane","to_label":"Human Resources and Compensation · Chair; Science and Technology","valid_from":"2015-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:16","evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:49:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"committee_of","from_id":"alpha:committee:teva-pharmaceutical-industries-ltd:science-and-technology","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Science and Technology","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:49","evidence_ids":["alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60"]},{"relationship_id":"alpha:relationship:member_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:49:committee:teva-pharmaceutical-industries-ltd:science-and-technology","relationship_type":"member_of","from_id":"alpha:person:perry-d-nisen","to_id":"alpha:committee:teva-pharmaceutical-industries-ltd:science-and-technology","from_label":"Perry D. Nisen","to_label":"Science and Technology","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:49","evidence_ids":["alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:12:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"committee_of","from_id":"alpha:committee:teva-pharmaceutical-industries-ltd:science-and-technology-compliance-human-resources-and-compensation","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Science and Technology; Compliance; Human Resources and Compensation","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":"2017-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:12","evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"]},{"relationship_id":"alpha:relationship:member_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:12:committee:teva-pharmaceutical-industries-ltd:science-and-technology-compliance-human-resources-and-compensation","relationship_type":"member_of","from_id":"alpha:person:perry-d-nisen","to_id":"alpha:committee:teva-pharmaceutical-industries-ltd:science-and-technology-compliance-human-resources-and-compensation","from_label":"Perry D. Nisen","to_label":"Science and Technology; Compliance; Human Resources and Compensation","valid_from":"2017-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:12","evidence_ids":["alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:18:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"executive_of","from_id":"alpha:person:amir-weiss","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Amir Weiss","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:18","evidence_ids":["alpha:projection-evidence:document:b35f77c27991bb5d53fb217d5341760f27e8ef78affed273ecede8c8ad564834"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:19:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"executive_of","from_id":"alpha:person:christopher-j-stevo","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Christopher J. Stevo","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:19","evidence_ids":["alpha:projection-evidence:document:3127308aa3cb1944dab9fc50df63e4750f721ac8840ba756fd276d7455831faa"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:20:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"executive_of","from_id":"alpha:person:david-r-mcavoy","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"David R. Mcavoy","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:20","evidence_ids":["alpha:projection-evidence:document:bedb35712599178b10aaea6d30b7f48140f30ad5a489d8713f6a88171b29f5e2"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:21:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"executive_of","from_id":"alpha:person:eliyahu-sharon-kalif","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Eliyahu Sharon Kalif","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:21","evidence_ids":["alpha:projection-evidence:document:6db10fc291abc3f16e22c4ed40ca600b9de6cc382722b58fa8aa8792d0ee3a4b"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:22:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"executive_of","from_id":"alpha:person:eric-a-hughes","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Eric A. Hughes","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:22","evidence_ids":["alpha:projection-evidence:document:2cfd57eb48fbc6e6cdb965ef825ffb62cb6e774aaa649b7c81c75212c2c163a1"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:23:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"executive_of","from_id":"alpha:person:kathleen-veit","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Kathleen Veit","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:23","evidence_ids":["alpha:projection-evidence:document:31e2475c90141d450c3ea7e98f59c770cc5891862868c22b4b4d49f78153f110"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:24:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"executive_of","from_id":"alpha:person:matthew-shields","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Matthew Shields","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:24","evidence_ids":["alpha:projection-evidence:document:2cd73c5146f224c38031862cb66c63314661926134e851ee01c2070e1334c9f8"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:25:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"executive_of","from_id":"alpha:person:richard-francis","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Richard Francis","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:25","evidence_ids":["alpha:projection-evidence:document:25b799e360910f8efe7c2a8d628d7396d74d0f78b80711428ba596e7f078a8e0"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:26:company:1ab4e417-6727-4cb7-8135-8765fcabc050","relationship_type":"executive_of","from_id":"alpha:person:richard-gordon-daniell","to_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","from_label":"Richard Gordon Daniell","to_label":"TEVA PHARMACEUTICAL INDUSTRIES LTD","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:26","evidence_ids":["alpha:projection-evidence:document:f847a8f21246910909e2a4e3b942bcbde32f052cba0510177821ccd7de82a59b"]}]},"claims":[{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:8","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:dr-sol-j-barer","object_label":"Sol J. Barer","object_source_name_forms":[],"value":"Sol J. Barer: Chairman of the Board","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:dr-sol-j-barer","name":"Sol J. Barer"},"title":"Chairman of the Board","role_category":"director","committee":null,"is_board_chair":true,"is_independent":true,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:17461fa3d5493d3b30182a87e5400dc5c54917c430dd17c64ebd57ff63626069","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A d11454ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312524097745/d11454ddef14a.htm","source_date":"2024-04-16T00:00:00+00:00","retrieved_at":"2026-09-02T01:54:50.166113+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2024-04-16T00:00:00+00:00","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:9","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:amir-elstein","object_label":"Amir Elstein","object_source_name_forms":[],"value":"Amir Elstein: Director, Corporate Governance and Nominating; Audit; Finance and Investment","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:amir-elstein","name":"Amir Elstein"},"title":"Director","role_category":"director","committee":"Corporate Governance and Nominating; Audit; Finance and Investment","is_board_chair":false,"is_independent":true,"start_date":"2009-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2009-01-01","valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"DEF 14A d11977ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm","source_date":"2026-05-28","retrieved_at":"2026-10-20T23:21:23.875049+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-28","effective_from":"2009-01-01","effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.9,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:10","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:chen-lichtenstein","object_label":"Chen Lichtenstein","object_source_name_forms":[],"value":"Chen Lichtenstein: Director, Audit; Compliance; Finance and Investment","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:chen-lichtenstein","name":"Chen Lichtenstein"},"title":"Director","role_category":"director","committee":"Audit; Compliance; Finance and Investment","is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"DEF 14A d11977ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm","source_date":"2026-05-28","retrieved_at":"2026-10-20T23:21:23.875049+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-28","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.9,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:11","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:gerald-lieberman","object_label":"Gerald Lieberman","object_source_name_forms":[],"value":"Gerald Lieberman: Director, Audit · Chair; Human Resources and Compensation; Finance and Investment","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:gerald-lieberman","name":"Gerald Lieberman"},"title":"Director","role_category":"director","committee":"Audit · Chair; Human Resources and Compensation; Finance and Investment","is_board_chair":false,"is_independent":true,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"DEF 14A d11977ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm","source_date":"2026-05-28","retrieved_at":"2026-10-20T23:21:23.875049+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-28","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.9,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:12","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:perry-d-nisen","object_label":"Perry D. Nisen","object_source_name_forms":[],"value":"Perry D. Nisen: Director, Science and Technology; Compliance; Human Resources and Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:perry-d-nisen","name":"Perry D. Nisen"},"title":"Director","role_category":"director","committee":"Science and Technology; Compliance; Human Resources and Compensation","is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"DEF 14A d11977ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm","source_date":"2026-05-28","retrieved_at":"2026-10-20T23:21:23.875049+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-28","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.9,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:13","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:prof-ronit-satchi-fainaro-tevjf","object_label":"Prof. Ronit Satchi-Fainaro","object_source_name_forms":[],"value":"Prof. Ronit Satchi-Fainaro: Director, Compliance; Science and Technology; Corporate Governance and Nominating","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:prof-ronit-satchi-fainaro-tevjf","name":"Prof. Ronit Satchi-Fainaro"},"title":"Director","role_category":"director","committee":"Compliance; Science and Technology; Corporate Governance and Nominating","is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:17461fa3d5493d3b30182a87e5400dc5c54917c430dd17c64ebd57ff63626069","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A d11454ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312524097745/d11454ddef14a.htm","source_date":"2024-04-16T00:00:00+00:00","retrieved_at":"2026-09-02T01:54:50.166113+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2024-04-16T00:00:00+00:00","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:14","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:richard-francis","object_label":"Richard Francis","object_source_name_forms":[],"value":"Richard Francis: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:richard-francis","name":"Richard Francis"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"DEF 14A d11977ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm","source_date":"2026-05-28","retrieved_at":"2026-10-20T23:21:23.875049+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-28","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.9,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:15","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:roberto-mignone","object_label":"Roberto Mignone","object_source_name_forms":[],"value":"Roberto Mignone: Director, Corporate Governance and Nominating · Chair; Finance and Investment; Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:roberto-mignone","name":"Roberto Mignone"},"title":"Director","role_category":"director","committee":"Corporate Governance and Nominating · Chair; Finance and Investment; Audit","is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"DEF 14A d11977ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm","source_date":"2026-05-28","retrieved_at":"2026-10-20T23:21:23.875049+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-28","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.9,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:16","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:rosemary-a-crane","object_label":"Rosemary A. Crane","object_source_name_forms":[],"value":"Rosemary A. Crane: Director, Human Resources and Compensation · Chair; Science and Technology","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:rosemary-a-crane","name":"Rosemary A. Crane"},"title":"Director","role_category":"director","committee":"Human Resources and Compensation · Chair; Science and Technology","is_board_chair":false,"is_independent":true,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"DEF 14A d11977ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm","source_date":"2026-05-28","retrieved_at":"2026-10-20T23:21:23.875049+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-28","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.9,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:17","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:tal-zaks","object_label":"Tal Zaks","object_source_name_forms":[],"value":"Tal Zaks: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:tal-zaks","name":"Tal Zaks"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"DEF 14A d11977ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm","source_date":"2026-05-28","retrieved_at":"2026-10-20T23:21:23.875049+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-28","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.9,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:18","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:amir-weiss","object_label":"Amir Weiss","object_source_name_forms":[],"value":"Amir Weiss: Senior VP & Chief Accounting Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:amir-weiss","name":"Amir Weiss"},"title":"Senior VP & Chief Accounting Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:b35f77c27991bb5d53fb217d5341760f27e8ef78affed273ecede8c8ad564834","identity_scope":"source_document_reference","source_type":"other","title":"Teva Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TEVA","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:26:01.037481+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-25","effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.86,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:19","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:christopher-j-stevo","object_label":"Christopher J. Stevo","object_source_name_forms":[],"value":"Christopher J. Stevo: Senior Vice President of Investor Relations & Competitive Intelligence","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:christopher-j-stevo","name":"Christopher J. Stevo"},"title":"Senior Vice President of Investor Relations & Competitive Intelligence","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:3127308aa3cb1944dab9fc50df63e4750f721ac8840ba756fd276d7455831faa","identity_scope":"source_document_reference","source_type":"other","title":"Teva Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TEVA","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:26:01.436606+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-25","effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.86,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:20","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:david-r-mcavoy","object_label":"David R. Mcavoy","object_source_name_forms":[],"value":"David R. Mcavoy: Executive VP & Chief Legal Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:david-r-mcavoy","name":"David R. Mcavoy"},"title":"Executive VP & Chief Legal Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:bedb35712599178b10aaea6d30b7f48140f30ad5a489d8713f6a88171b29f5e2","identity_scope":"source_document_reference","source_type":"other","title":"Teva Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TEVA","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:26:01.846702+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-25","effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.86,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:21","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:eliyahu-sharon-kalif","object_label":"Eliyahu Sharon Kalif","object_source_name_forms":[],"value":"Eliyahu Sharon Kalif: Executive VP & CFO","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:eliyahu-sharon-kalif","name":"Eliyahu Sharon Kalif"},"title":"Executive VP & CFO","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:6db10fc291abc3f16e22c4ed40ca600b9de6cc382722b58fa8aa8792d0ee3a4b","identity_scope":"source_document_reference","source_type":"other","title":"Teva Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TEVA","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:26:02.25457+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-25","effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.86,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:22","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:eric-a-hughes","object_label":"Eric A. Hughes","object_source_name_forms":[],"value":"Eric A. Hughes: Executive Vice President of Global R&D and Chief Medical Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:eric-a-hughes","name":"Eric A. Hughes"},"title":"Executive Vice President of Global R&D and Chief Medical Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:2cfd57eb48fbc6e6cdb965ef825ffb62cb6e774aaa649b7c81c75212c2c163a1","identity_scope":"source_document_reference","source_type":"other","title":"Teva Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TEVA","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:26:00.200356+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-25","effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.86,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:23","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:kathleen-veit","object_label":"Kathleen Veit","object_source_name_forms":[],"value":"Kathleen Veit: Senior Vice President, Global Compliance & Ethics Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:kathleen-veit","name":"Kathleen Veit"},"title":"Senior Vice President, Global Compliance & Ethics Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:31e2475c90141d450c3ea7e98f59c770cc5891862868c22b4b4d49f78153f110","identity_scope":"source_document_reference","source_type":"other","title":"Teva Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TEVA","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:26:00.678073+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-25","effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.86,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:24","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:matthew-shields","object_label":"Matthew Shields","object_source_name_forms":[],"value":"Matthew Shields: Executive Vice President of Global Operations","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:matthew-shields","name":"Matthew Shields"},"title":"Executive Vice President of Global Operations","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:2cd73c5146f224c38031862cb66c63314661926134e851ee01c2070e1334c9f8","identity_scope":"source_document_reference","source_type":"other","title":"Teva Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TEVA","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:26:02.668879+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-25","effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.86,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:25","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:richard-francis","object_label":"Richard Francis","object_source_name_forms":[],"value":"Richard Francis: President, Chief Executive Officer & Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:richard-francis","name":"Richard Francis"},"title":"President, Chief Executive Officer & Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:25b799e360910f8efe7c2a8d628d7396d74d0f78b80711428ba596e7f078a8e0","identity_scope":"source_document_reference","source_type":"other","title":"Teva Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TEVA","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:26:03.045066+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-25","effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.86,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:26","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:richard-gordon-daniell","object_label":"Richard Gordon Daniell","object_source_name_forms":[],"value":"Richard Gordon Daniell: Executive Vice President of European Commercial","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:richard-gordon-daniell","name":"Richard Gordon Daniell"},"title":"Executive Vice President of European Commercial","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:document:f847a8f21246910909e2a4e3b942bcbde32f052cba0510177821ccd7de82a59b","identity_scope":"source_document_reference","source_type":"other","title":"Teva Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TEVA","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:26:03.469628+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-25","effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.86,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:27","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Gerald Lieberman; Members Gerald Lieberman (Chair); Amir Elstein; Chen Lichtenstein; Roberto Mignone","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Gerald Lieberman","members":[{"display_name":"Gerald Lieberman","person_slug":"gerald-lieberman","is_chair":true},{"display_name":"Amir Elstein","person_slug":"amir-elstein","is_chair":false},{"display_name":"Chen Lichtenstein","person_slug":"chen-lichtenstein","is_chair":false},{"display_name":"Roberto Mignone","person_slug":"roberto-mignone","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60","identity_scope":"representation_reference","source_type":"sec_def_14a","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:32","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compliance: Chair not stated; Members Chen Lichtenstein; Perry D. Nisen; Prof. Ronit Satchi-Fainaro","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compliance","canonical_type":"other","chair":null,"members":[{"display_name":"Chen Lichtenstein","person_slug":"chen-lichtenstein","is_chair":false},{"display_name":"Perry D. Nisen","person_slug":"perry-d-nisen","is_chair":false},{"display_name":"Prof. Ronit Satchi-Fainaro","person_slug":"prof-ronit-satchi-fainaro-tevjf","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60","identity_scope":"representation_reference","source_type":"sec_def_14a","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:36","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Corporate Governance and Nominating: Chair Roberto Mignone; Members Roberto Mignone (Chair); Amir Elstein; Prof. Ronit Satchi-Fainaro","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Corporate Governance and Nominating","canonical_type":"nominating_governance","chair":"Roberto Mignone","members":[{"display_name":"Roberto Mignone","person_slug":"roberto-mignone","is_chair":true},{"display_name":"Amir Elstein","person_slug":"amir-elstein","is_chair":false},{"display_name":"Prof. Ronit Satchi-Fainaro","person_slug":"prof-ronit-satchi-fainaro-tevjf","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60","identity_scope":"representation_reference","source_type":"sec_def_14a","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:40","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Finance and Investment: Chair not stated; Members Amir Elstein; Chen Lichtenstein; Gerald Lieberman; Roberto Mignone","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Finance and Investment","canonical_type":"other","chair":null,"members":[{"display_name":"Amir Elstein","person_slug":"amir-elstein","is_chair":false},{"display_name":"Chen Lichtenstein","person_slug":"chen-lichtenstein","is_chair":false},{"display_name":"Gerald Lieberman","person_slug":"gerald-lieberman","is_chair":false},{"display_name":"Roberto Mignone","person_slug":"roberto-mignone","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60","identity_scope":"representation_reference","source_type":"sec_def_14a","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:45","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Human Resources and Compensation: Chair Rosemary A. Crane; Members Rosemary A. Crane (Chair); Gerald Lieberman; Perry D. Nisen","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Human Resources and Compensation","canonical_type":"compensation","chair":"Rosemary A. Crane","members":[{"display_name":"Rosemary A. Crane","person_slug":"rosemary-a-crane","is_chair":true},{"display_name":"Gerald Lieberman","person_slug":"gerald-lieberman","is_chair":false},{"display_name":"Perry D. Nisen","person_slug":"perry-d-nisen","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60","identity_scope":"representation_reference","source_type":"sec_def_14a","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:49","subject_id":"alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Science and Technology: Chair not stated; Members Perry D. Nisen; Prof. Ronit Satchi-Fainaro; Rosemary A. Crane","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Science and Technology","canonical_type":"technology","chair":null,"members":[{"display_name":"Perry D. Nisen","person_slug":"perry-d-nisen","is_chair":false},{"display_name":"Prof. Ronit Satchi-Fainaro","person_slug":"prof-ronit-satchi-fainaro-tevjf","is_chair":false},{"display_name":"Rosemary A. Crane","person_slug":"rosemary-a-crane","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:45:10.88591+00:00","sources":[{"id":"alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60","identity_scope":"representation_reference","source_type":"sec_def_14a","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:17461fa3d5493d3b30182a87e5400dc5c54917c430dd17c64ebd57ff63626069","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A d11454ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312524097745/d11454ddef14a.htm","source_date":"2024-04-16T00:00:00+00:00","retrieved_at":"2026-09-02T01:54:50.166113+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"DEF 14A d11977ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm","source_date":"2026-05-28","retrieved_at":"2026-10-20T23:21:23.875049+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:b35f77c27991bb5d53fb217d5341760f27e8ef78affed273ecede8c8ad564834","identity_scope":"source_document_reference","source_type":"other","title":"Teva Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TEVA","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:26:01.037481+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:3127308aa3cb1944dab9fc50df63e4750f721ac8840ba756fd276d7455831faa","identity_scope":"source_document_reference","source_type":"other","title":"Teva Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TEVA","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:26:01.436606+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:bedb35712599178b10aaea6d30b7f48140f30ad5a489d8713f6a88171b29f5e2","identity_scope":"source_document_reference","source_type":"other","title":"Teva Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TEVA","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:26:01.846702+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:6db10fc291abc3f16e22c4ed40ca600b9de6cc382722b58fa8aa8792d0ee3a4b","identity_scope":"source_document_reference","source_type":"other","title":"Teva Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TEVA","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:26:02.25457+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:2cfd57eb48fbc6e6cdb965ef825ffb62cb6e774aaa649b7c81c75212c2c163a1","identity_scope":"source_document_reference","source_type":"other","title":"Teva Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TEVA","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:26:00.200356+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:31e2475c90141d450c3ea7e98f59c770cc5891862868c22b4b4d49f78153f110","identity_scope":"source_document_reference","source_type":"other","title":"Teva Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TEVA","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:26:00.678073+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:2cd73c5146f224c38031862cb66c63314661926134e851ee01c2070e1334c9f8","identity_scope":"source_document_reference","source_type":"other","title":"Teva Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TEVA","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:26:02.668879+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:25b799e360910f8efe7c2a8d628d7396d74d0f78b80711428ba596e7f078a8e0","identity_scope":"source_document_reference","source_type":"other","title":"Teva Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TEVA","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:26:03.045066+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:f847a8f21246910909e2a4e3b942bcbde32f052cba0510177821ccd7de82a59b","identity_scope":"source_document_reference","source_type":"other","title":"Teva Pharmaceutical key executives","publisher":null,"url":"https://financialmodelingprep.com/stable/key-executives?symbol=TEVA","source_date":"2026-04-25","retrieved_at":"2026-04-25T00:26:03.469628+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60","identity_scope":"representation_reference","source_type":"sec_def_14a","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.807,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.792,"cross_source_agreement":0.75,"temporal_completeness":0.256},"diagnostics":{"published_claims":53,"factual_claims":53,"claims_with_linked_evidence":53,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":39,"temporal_claims_with_valid_from":10,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-24T04:45:10.88591+00:00","observed_at":"2026-10-24T04:45:10.88591+00:00","reviewed_at":"2026-10-24T04:45:10.88591+00:00","verified_at":"2026-10-24T04:45:10.88591+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":53,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/teva-pharmaceutical-industries-ltd/relationships","section":"relationships","href":"https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record&section=relationships","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}